Convertible Notes (Details Narrative) - USD ($)	3 Months Ended				9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2021	Dec. 31, 2020
Accrued interest					$ 397
Shares of common stock					137,996
Convertible notes payable, net of debt discount					$ 0	$ 103,920
Debt instrument, conversion of shares					597,139
Common stock value for service provider					$ 0
Accrued compensation					45,000
Beneficial conversion feature	$ 234,912	$ 170,796	$ 150,056	$ 2,015
Medical advisor [Member]
Convertible notes payable, net of debt discount					115,000	103,920
Accrued compensation					90,000
Debt instrument, principal balance					$ 295,000	205,000
Maturity Date					Mar. 31, 2021
Debt instrument debt discount					$ 90,000	101,080
Price per share					$ 0.50
Lower price per share					0.85
Unamortized debt discount					$ 0	$ 101,080
Interest Rate					3.00%
Amortization debt discount					$ 191,080
Beneficial conversion feature					90,000
Legal Counsel [Member]
Common stock value for service provider					$ 176,502
Debt instrument, conversion of shares					350,000
Accrued compensation					$ 3,595
Interest Expense					1,502
Debt instrument, principal balance					175,000
Two Unaffiliated Individuals [Member]
Interest Expense					$ 32,412
Price per share					$ 0.85
Interest Rate					3.00%
Beneficial conversion feature					$ 32,412
Proceeds from convertible notes payable					$ 115,000